October 24th, 2017|News|
October 24, 2017 Ann Arbor, MI: Aquaro Histology, Inc. (formerly known as Aquaro Biosystems, LLC) announced today the completion of a Series A funding round of $9.8 million led by Telegraph Hill Partners. This investment will enable Aquaro Histology [...]
September 27th, 2017|News|
San Diego, CA, September 27, 2017 – Agena Bioscience today announced a comparative study published in PLOS ONE highlighting the use of its mass spectrometry-based platform and new, highly sensitive iPLEX® HS chemistry for detection of somatic mutatio [...]
September 11th, 2017|News|
TrakCel Solution will electronically link Iovance with clinical sites, contract manufacturing organizations and couriers to schedule and track TIL therapies for each patient SAN CARLOS, Calif., Sept. 11, 2017 (GLOBE NEWSWIRE) -- Iovance Biotherapeuti [...]
September 7th, 2017|Uncategorized|
TrakCel solution integration with Cell and Gene Therapy Catapult manufacturing centre enables needle-to-needle supply chain management at any scale London, UK, September 7, 2017 - TrakCel today announced a partnership agreement to incorporate its nee [...]
August 29th, 2017|Uncategorized|
Seattle, WA, August 24, 2017 – RareCyte, Inc., a global rare cell detection and liquid biopsy company will use the funding to advance its commercial sales efforts and build companion diagnostics (CDx) programs with strategic partners. The Company wil [...]
August 24th, 2017|News|
San Diego--(BUSINESS WIRE)—August 24, 2017-- Illumina Inc. (NASDAQ: ILMN) today announced plans with Telegraph Hill Partners (THP), a San Francisco-based venture capital and growth equity firm, to establish Verogen, Inc. The independent new company h [...]
August 2nd, 2017|News|
San Diego, CA, August 2, 2017– Agena Bioscience has entered into a 3-year agreement with the Illinois Department of Public Health (IDPH) which will deploy Agena’s MassARRAY System for Cystic Fibrosis (CF) testing as part of the state’s newborn screen [...]
August 2nd, 2017|News|
AUSTIN, Texas--(BUSINESS WIRE)-- Asuragen, Inc., a molecular diagnostics company changing the way diagnostics impact patient care in genetics and oncology, announced today the availability of their CE-marked QuantideX® qPCR BCR-ABL minor Kit*. Buildi [...]
June 29th, 2017|News|
SAN DIEGO, Calif., June 29, 2017– Agena Bioscience today announced the European launch of the MassARRAY® System with CHIP Prep Module (CPM), marketed as a CE-IVD product under the Directive 98/79/EC for in vitro diagnostic medical devices. The MassAR [...]
June 20th, 2017|News|
MassARRAY® System Selected for Assurex Health’s GeneSight Test SAN DIEGO, Calif., June 20, 2017– Agena Bioscience today announced that Assurex Heath, a wholly owned subsidiary of Myriad Genetics, Inc., has selected the MassARRAY® System for streamlin [...]
